Nestlé (SWX:NESN) has agreed to sell its mainstream vitamins, minerals and supplements portfolio, known as the Holistic Health portfolio, to Yellow Wood Partners for $1b. The deal focuses Nestlé on premium, science led VMS assets.
At a share price of CHF78.63, Nestlé’s short term share price return has been slightly positive year to date at 2.86%, while the 1 year total shareholder return of 9.54% contrasts with declines over the 3 and 5 year total return periods. Recent portfolio moves around vitamins, minerals and supplements, including the review of The Better Health Company in New Zealand earlier in 2026, help explain why investors are reassessing both growth potential and risk as the company refines where it commits capital.
Compare Nestlé's portfolio reshaping with other consumer stocks that screen strongly on cash flows and balance sheet strength in our hand picked 265 high quality undervalued stocks list.
Nestlé has streamlined its vitamins portfolio and the stock already reflects a recovery after weak 3 and 5 year returns. The next step is to test whether the current price still leaves clear upside on the table.
The most followed narrative on Nestlé sees fair value at CHF91.08 per share, compared with the last close at CHF78.63, which implies meaningful upside in that framework.
Nestlé is no longer a high-growth company, but a global compounder transforming toward higher-value nutrition categories. The key investment thesis is that Nestlé can gradually improve profitability through:
Want to see what sits behind that profitability story? The narrative is based on modest revenue growth, firmer margins and a re-rated profit multiple to reach its fair value.
Result: Fair Value of CHF91.08 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Nestlé still faces risks if consumer demand weakens in key regions or if the shift toward higher value nutrition products results in slower profit improvement than expected.
Find out about the key risks to this Nestlé narrative.
The user narrative leans on a fair value near CHF91 per share. The market picture looks different when you focus on Nestlé’s current P/E of 27.2x. That is higher than both European food peers at 22.8x and the sector average at 16.3x, even though the fair ratio points to 30.4x as a level the market could move toward. For you as an investor, that mix of “expensive to peers but below the fair ratio” means the upside case relies heavily on earnings quality and growth forecasts holding up. Which signal do you treat as more important right now: the peer premium, or the gap to the fair ratio?
See what the numbers say about this price — find out in our valuation breakdown.
If this Nestlé story appears evenly balanced between opportunity and risk, consider acting promptly and test the numbers yourself using the 2 key rewards and 3 important warning signs.
If you stop at Nestlé, you could miss stocks that better fit your goals. Use the Simply Wall Street Screener to quickly surface ideas that match your risk and income preferences.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com